Literature DB >> 10967107

Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter.

S B Smith1, H Watada, D W Scheel, C Mrejen, M S German.   

Abstract

During pancreatic development, the paired homeodomain transcription factor PAX4 is required for the differentiation of the insulin-producing beta cells and somatostatin-producing delta cells. To establish the position of PAX4 in the hierarchy of factors controlling islet cell development, we examined the control of the human PAX4 gene promoter. In both cell lines and transgenic animals, a 4.9-kilobase pair region directly upstream of the human PAX4 gene transcriptional start site acts as a potent pancreas-specific promoter. Deletion mapping experiments demonstrate that a 118-base pair region lying approximately 1.9 kilobase pairs upstream of the transcription start site is both necessary and sufficient to direct pancreas-specific expression. Serial deletions through this region reveal the presence of positive elements that bind several pancreatic transcription factors as follows: the POU homeodomain factor HNF1alpha, the orphan nuclear receptor HNF4alpha, the homeodomain factor PDX1, and a heterodimer composed of two basic helix-loop-helix factors. Interestingly, mutations in the genes encoding four of these factors cause a dominantly inherited form of human diabetes called Maturity Onset Diabetes of the Young. In addition, PAX4 itself has at least two high affinity binding sites within the promoter through which it exerts a strong negative autoregulatory effect. Together, these results suggest a model in which PAX4 expression is activated during pancreatic development by a combination of pancreas-specific factors but is then switched off once PAX4 protein reaches sufficient levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967107     DOI: 10.1074/jbc.M005202200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  A small molecule differentiation inducer increases insulin production by pancreatic β cells.

Authors:  Elhadji M Dioum; Jihan K Osborne; Sean Goetsch; Jamie Russell; Jay W Schneider; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 3.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 4.  Translational implications of the β-cell epigenome in diabetes mellitus.

Authors:  Justin S Johnson; Carmella Evans-Molina
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

Review 5.  Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases.

Authors:  Vidul Goenka; Tanhai Borkar; Aska Desai; Raunak Kumar Das
Journal:  J Diabetes Metab Disord       Date:  2020-10-17

6.  Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.

Authors:  A Biason-Lauber; B Boehm; M Lang-Muritano; B R Gauthier; T Brun; C B Wollheim; E J Schoenle
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

7.  Overexpression of PAX4 reduces glucagon expression in differentiating hESCs.

Authors:  Blair K Gage; Robert K Baker; Timothy J Kieffer
Journal:  Islets       Date:  2014       Impact factor: 2.694

Review 8.  Pancreas cell fate.

Authors:  Michelle A Guney; Maureen Gannon
Journal:  Birth Defects Res C Embryo Today       Date:  2009-09

Review 9.  A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis.

Authors:  Daniella A Babu; Tye G Deering; Raghavendra G Mirmira
Journal:  Mol Genet Metab       Date:  2007-07-30       Impact factor: 4.797

10.  Efficient, glucose responsive and islet-specific transgene expression by a modified rat insulin promoter.

Authors:  R Chai; S Chen; J Ding; P A Grayburn
Journal:  Gene Ther       Date:  2009-09-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.